Sale of 6,938 shares at $10.56 per share.
Reporting Person Buell Jennifer · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 12, 2026 · Disclosed Oct 14, 2026
Source: SEC Form 4 · 0001193125-26-421529 · filed 2026-10-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "MiNK Therapeutics, Inc. (INKT)." Disclosed 2026-10-14. https://desqlong.com/cards/0001193125-26-421529-2 (retrieved 2026-10-15).